Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020.

MLA

Veliziotis, Ioannis, et al. “Clinical Management of Argentine Hemorrhagic Fever Using Ribavirin and Favipiravir, Belgium, 2020.” Emerging Infectious Diseases, vol. 26, no. 7, July 2020, pp. 1562–66. EBSCOhost, https://doi.org/10.3201/eid2607.200275.

APA

Veliziotis, I., Roman, A., Martiny, D., Schuldt, G., Claus, M., Dauby, N., Van den Wijngaert, S., Martin, C., Nasreddine, R., Perandones, C., Mahieu, R., Swaan, C., Van Praet, S., Konopnicki, D., Morales, M. A., Malvy, D., Stevens, E., Dechamps, P., Vlieghe, E., & Vandenberg, O. (2020). Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020. Emerging Infectious Diseases, 26(7), 1562–1566. https://doi.org/10.3201/eid2607.200275

Chicago

Veliziotis, Ioannis, Alain Roman, Delphine Martiny, Gerlind Schuldt, Marc Claus, Nicolas Dauby, Sigi Van den Wijngaert, et al. 2020. “Clinical Management of Argentine Hemorrhagic Fever Using Ribavirin and Favipiravir, Belgium, 2020.” Emerging Infectious Diseases 26 (7): 1562–66. doi:10.3201/eid2607.200275.